Cargando…
Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
Febrile neutropenia (FN) is a frequent complication of cancer treatment in children. Owing to the potential for overwhelming bacterial sepsis, the recognition and management of FN requires rapid implementation of evidenced-based management protocols. Treatment paradigms have progressed from hospital...
Autores principales: | Morgan, Jessica E, Phillips, Bob, Haeusler, Gabrielle M, Chisholm, Julia C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019605/ https://www.ncbi.nlm.nih.gov/pubmed/33833534 http://dx.doi.org/10.2147/IDR.S238567 |
Ejemplares similares
-
Individual participant data validation of the PICNICC prediction model for febrile neutropenia
por: Phillips, Bob, et al.
Publicado: (2020) -
Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia
por: Haeusler, Gabrielle M, et al.
Publicado: (2020) -
Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia
por: Doerflinger, Marcel, et al.
Publicado: (2021) -
PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study
por: Morgan, Jessica Elizabeth, et al.
Publicado: (2022) -
Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia
por: Morgan, Jessica E, et al.
Publicado: (2014)